|
US2006281724A1
|
|
Methods for Treating Shock
|
|
US2006281720A1
|
|
5-Androstenediol As An Inhibitor of Gliomas
|
|
AU2003222070A1
|
|
AlphaAED AND BetaAED REGULATION OF NUCLEAR TRANSCRIPTION, GENE REGULATION, AND/OR GENE EXPRESSION
|
|
US6977251B2
|
|
5-androstene-3β, 17α diol as an inhibitor of tumor growth
|
|
CA2578825A1
|
|
5-androstene 3.beta., 17.alpha. diol as an inhibitor of tumor growth
|
|
EP1362591A1
|
|
Use of a composition containing 5-androstene-3beta,17alpha-diol
|
|
CA2252110A1
|
|
5-androstene 3.beta.,17.alpha. diol as an inhibitor of tumor growth
|
|
WO9737662A1
|
|
5-ANDROSTENE 3β,17α DIOL AS AN INHIBITOR OF TUMOR GROWTH
|
|
WO9423722A1
|
|
Hydrocortisone buffering activity
|
|
WO9321774A1
|
|
Method of balancing oils and fats to enhance health
|
|
US5077284A
|
|
Use of dehydroepiandrosterone to improve immune response
|
